Effect of H.Pylori Infection on Growth Parameters
NCT06938035 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2025-04-22
Summary
This study aimed to assess the effect H.pylori infection on growth parameter Of primary school-aged children Attending Assuit university chilren hospital
Conditions
- HELICOBACTER PYLORI INFECTIONS
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 6 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-13
- Primary Completion
- 2025-12-31
- Completion
- 2026-03-31
More Related Trials
-
Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
NCT03556254 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children
NCT02302170 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA
-
Feasibility Study to Diagnose Helicobacter Pylori in the Paediatric Population Using Non-invasive Fecal Analysis
NCT07083804 ·Status: RECRUITING
-
Improving Antibiotic Prescribing for Pediatric Respiratory Infections by Family Physicians With Peer Comparison
NCT04588376 ·Status: COMPLETED ·Phase: NA
-
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT05332444 ·Status: RECRUITING ·Phase: PHASE4
-
Establish Epidemiologic Data of H. Pylori Infection in Children and Adolescents-Using C13-UBT
NCT00155623 ·Status: COMPLETED
-
A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
NCT02689583 ·Status: UNKNOWN ·Phase: NA
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
NCT03571230 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of 7-day Triple Therapy Containing Amoxicillin and Tetracycline Versus 14-day Dual Therapy for Helicobacter Pylori Eradication
NCT07333001 ·Status: COMPLETED
-
Registry for the Management of Helicobacter Pylori Infection in Shandong Province
NCT07335406 ·Status: RECRUITING
-
Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin
NCT05129176 ·Status: UNKNOWN ·Phase: PHASE4
-
Performances of a H. Pylori Stool PCR Test
NCT03566004 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Different Acid Suppressors in Bismuth-containing Quadruple Therapy Against Helicobacter Pylori
NCT05301725 ·Status: COMPLETED
-
The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.
NCT03583476 ·Status: UNKNOWN
-
High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)
NCT07121205 ·Status: COMPLETED
-
Second Line Bismuth Containing Quadruple Therapy With Supplementary Probiotic
NCT05577572 ·Status: UNKNOWN ·Phase: NA
-
The Study of the Antimicrobial Resistance of Helicobacter Pylori in Shandong Province
NCT04029415 ·Status: UNKNOWN
-
A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
NCT02923856 ·Status: UNKNOWN ·Phase: NA
-
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses
NCT05431075 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication
NCT01163435 ·Status: COMPLETED ·Phase: PHASE4
-
Helicobacter Pylori Infection Occurrence in Russia
NCT04892238 ·Status: COMPLETED
-
Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment
NCT02935010 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication
NCT04527055 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Telephone-Based Re-education for Hp Eradication
NCT03193450 ·Status: COMPLETED ·Phase: NA